Variable Clinical Courses of Varicella Zoster Virus Infection–related or Vaccination-related Bone Marrow Failure

Author:

Toskov Vasil1,Cseh Annamaria12,Claviez Alexander3,Drexler Beatrice14,Rotari Natalia1,Schwarz-Furlan Stephan56,Braun Matthias7,Bader Peter8,Lang Peter9,Beier Rita10,Erdlenbruch Bernhard11,Führer Monika12,Erlacher Miriam1,Niemeyer Charlotte M.1,Strahm Brigitte1,Yoshimi Ayami1

Affiliation:

1. Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg

2. Department of Stem Cell Transplantation, St. Anna Children’s Hospital, Medical University of Vienna, Vienna, Austria

3. Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel

4. Department of Medicine, Division of Hematology, University Hospital Basel, Basel, Switzerland

5. Institute of Pathology, Klinikum Kaufbeuren-Ravensburg, Kaufbeuren

6. Institute of Pathology, University Hospital Erlangen, Erlangen

7. Department of Padiatrische Hamatologie und Onkologie, Zentrum fur Kinderheiikunde der Justus-Liebig-Universitat Giessen, Giessen

8. Department for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, Frankfurt am Main

9. Department of Hematology/Oncology and General Pediatrics, Children’s University Hospital, University of Tübingen, Tübingen

10. Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover

11. Department of Pediatrics, Johannes Wesling Klinikum Minden, Ruhr-University Bochum, Minden

12. Center for Pediatric Palliative Care, Dr von Hauner Children’s Hospital, University of Munich, Munich, Germany

Abstract

We report 5 children with bone marrow failure (BMF) after primary varicella zoster virus (VZV) infection or VZV vaccination, highlighting the highly variable course. Two patients were treated with intravenous immunoglobulins; one had a slow hematologic recovery, and the other was rescued by allogeneic hematopoietic stem cell transplantation (HSCT). Of the 2 patients treated with immunosuppressive therapy with antithymocyte globulin and cyclosporine, one had a complete response, and the other was transplanted for nonresponse. One patient underwent a primary allograft. All patients are alive. This study demonstrated that VZV-associated BMF is a life-threatening disorder that often requires HSCT.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference20 articles.

1. Don’t forget how severe varicella can be—complications of varicella in children in a defined Polish population;Gowin;Int J Infect Dis,2013

2. Haematological complications in otherwise healthy children hospitalized for varicella;Elena;Vaccine,2011

3. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997–2005;Chaves;J Infect Dis,2008

4. Aplastic anemia following varicella vaccine;Angelini;Pediatric Infect Dis J,2009

5. Four year old child with breakthrough varicella leading to pancytopenia;Kakish;Bahrain Medical Bulletin,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3